These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15931718)

  • 21. [Clinical utility of natriuretic peptdies in dyspnea].
    Müller C
    Ther Umsch; 2009 Sep; 66(9):649-52. PubMed ID: 19725009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Impact of natriuretic peptides in current clinical practice].
    Ganovská E; Špinar J; Pařenica J
    Vnitr Lek; 2014; 60(5-6):474-83. PubMed ID: 24974752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Expert consensus on the usefulness of natriuretic peptides in heart failure.].
    Nessler J; Straburzyńska-Migaj E; Windak A; Solnica B; Szmitkowski M; Paradowski M; Kaźmierczak J; Puacz E; Rozentryt P
    Kardiol Pol; 2018; 76(1):215-224. PubMed ID: 29399772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical decision support using machine learning and natriuretic peptides for the diagnosis of acute heart failure.
    Lee KK; Doudesis D; Mair J; Mills NL;
    Eur Heart J Acute Cardiovasc Care; 2024 Jun; 13(6):515-516. PubMed ID: 38753847
    [No Abstract]   [Full Text] [Related]  

  • 25. Natriuretic Peptides: Consensus Call for Use.
    Pascual Figal DA; Casademont J; Lobos JM; Piñera P; Bayes-Genis A; Ordóñez Llanos J; González-Juanatey JR
    Rev Esp Cardiol (Engl Ed); 2016 Sep; 69(9):817-9. PubMed ID: 27236277
    [No Abstract]   [Full Text] [Related]  

  • 26. Recent advances in point-of-care testing for natriuretic peptides: potential impact on heart failure diagnosis and management.
    Iwaz JA; Maisel AS
    Expert Rev Mol Diagn; 2016 Jun; 16(6):641-50. PubMed ID: 26919295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased soluble ST2 is a stronger predictor of long-term cardiovascular death than natriuretic peptides in heart failure patients with reduced ejection fraction.
    Gruson D; Lepoutre T; Ahn SA; Rousseau MF
    Int J Cardiol; 2014; 172(1):e250-2. PubMed ID: 24467978
    [No Abstract]   [Full Text] [Related]  

  • 28. Hypervolemic and optivolemic natriuretic peptides in acute heart failure.
    Xue Y; Taub PR; Fard A; Maisel AS
    Contrib Nephrol; 2011; 171():74-79. PubMed ID: 21625093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Natriuretic peptides in heart failure].
    Emdin M; Poletti R; Giannoni A; Mazzei MG; Mammini C; Gabutti A; Agazio A; Caprioli R; Passino C
    G Ital Nefrol; 2006; 23 Suppl 34():S32-7. PubMed ID: 16633992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical relevance of non-cardiac determinants of natriuretic peptide levels.
    Passino C; Poletti R; Fontana M; Vergaro G; Prontera C; Gabutti A; Giannoni A; Emdin M; Clerico A
    Clin Chem Lab Med; 2008; 46(11):1515-23. PubMed ID: 19012517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical benefits of natriuretic peptides and galectin-3 are maintained in old dyspnoeic patients.
    Teixeira A; Arrigo M; Vergaro G; Cohen-Solal A; Mebazaa A
    Arch Gerontol Geriatr; 2017; 68():33-38. PubMed ID: 27611369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Role of biomarkers for risk stratification in the tailored follow-up of heart failure patients].
    Aspromonte N; Di Tano G; Latini R; Masson S; Valle R; Emdin M
    G Ital Cardiol (Rome); 2010 May; 11(5 Suppl 2):17S-23S. PubMed ID: 20873464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natriuretic peptides in the diagnosis and management of acute heart failure.
    Mohammed AA; Januzzi JL
    Heart Fail Clin; 2009 Oct; 5(4):489-500. PubMed ID: 19631174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood biomarker measurement as disease target: the case for generic treatment of high natriuretic peptide levels without a diagnosis of heart failure.
    Clark AL
    J R Coll Physicians Edinb; 2013; 43(2):99-100. PubMed ID: 23734347
    [No Abstract]   [Full Text] [Related]  

  • 35. [Biomarkers in heart failure: are they clinically useful?].
    Kempf T; Wollert KC
    Dtsch Med Wochenschr; 2009 Apr; 134(15):740-6. PubMed ID: 19340752
    [No Abstract]   [Full Text] [Related]  

  • 36. Changes in natriuretic peptides after acute hospital presentation for heart failure with preserved ejection fraction: A feasible surrogate trial endpoint? A report from the prospective Karen study.
    Savarese G; Donal E; Hage C; Oger E; Persson H; Daubert JC; Linde C; Lund LH;
    Int J Cardiol; 2017 Jan; 226():65-70. PubMed ID: 27788392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natriuretic peptide measurements as part of the diagnostic work-up in pleural effusions: an emerging concept?
    Mueller T; Haltmayer M
    Eur Respir J; 2006 Jul; 28(1):7-9. PubMed ID: 16816345
    [No Abstract]   [Full Text] [Related]  

  • 38. [Sequential Natriuretic Peptide Measurements to Monitor Treatment and Prognosis During Heart Failure Therapy].
    Becher MU
    Dtsch Med Wochenschr; 2020 Apr; 145(7):458-463. PubMed ID: 32236926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The potential role of natriuretic peptide-guided management for patients hospitalized for heart failure.
    Maisel A; Xue Y; Greene SJ; Pang PS; Januzzi JL; Piña IL; DeFilippi C; Butler J
    J Card Fail; 2015 Mar; 21(3):233-9. PubMed ID: 25433362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Usefulness of natriuretic peptides in heart failure].
    Jiménez-Navarro M; Delgado Jiménez J; Rivera Otero M; Roig Minguell E; Segovia Cubero J; Almenar Bonet L; Anguita Sánchez M; Bayés-Genís A; Crespo Leiro MG
    Med Clin (Barc); 2008 Apr; 130(15):591-6. PubMed ID: 18462639
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.